Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kelly E. Pearson
Institution:
Mirati Therapeutics (United States)
Observed institution:
Mirati Therapeutics (United States)
ORCID:
0009-0003-8528-833X
Observed ORCID:
0009-0003-8528-833X
OpenAlex ID:
A5103096857
Discovery of Pyridopyrimidinones that Selectively Inhibit the H1047R PI3Kα Mutant Protein
2024
·
John M. Ketcham
, Stephen J. Harwood
, et al.
·
Journal of Medicinal Chemistry
·
27
Discovery of Five SOS2 Fragment Hits with Binding Modes Determined by SOS2 X-Ray Cocrystallography
2023
·
Christopher R. Smith
, Dan Chen
, et al.
·
Journal of Medicinal Chemistry
·
9
PDF
Stereoselective Amine Synthesis Mediated by a Zirconocene Hydride to Accelerate a Drug Discovery Program
2024
·
Athenea N. Aloiau
, Briana M. Bobek
, et al.
·
The Journal of Organic Chemistry
·
6
Zirconium Hydride Catalysis Initiated by Tetrabutylammonium Fluoride
2024
·
Athenea N. Aloiau
, Briana M. Bobek
, et al.
·
The Journal of Organic Chemistry
·
2
Show more works
View as search
Works count:
4
Citation count:
44
H-index:
3
I10-index:
1
Year
Topic
Type
